Alignment Healthcare Llc Stock Alpha and Beta Analysis
| ALHC Stock | USD 20.93 0.37 1.74% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Alignment Healthcare LLC. It also helps investors analyze the systematic and unsystematic risks associated with investing in Alignment Healthcare over a specified time horizon. Remember, high Alignment Healthcare's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Alignment Healthcare's market risk premium analysis include:
Beta 1.18 | Alpha 0.29 | Risk 2.2 | Sharpe Ratio 0.15 | Expected Return 0.34 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Alignment | Build AI portfolio with Alignment Stock |
Alignment Healthcare Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Alignment Healthcare market risk premium is the additional return an investor will receive from holding Alignment Healthcare long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Alignment Healthcare. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Alignment Healthcare's performance over market.| α | 0.29 | β | 1.18 |
Alignment Healthcare expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Alignment Healthcare's Buy-and-hold return. Our buy-and-hold chart shows how Alignment Healthcare performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Alignment Healthcare Market Price Analysis
Market price analysis indicators help investors to evaluate how Alignment Healthcare stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Alignment Healthcare shares will generate the highest return on investment. By understating and applying Alignment Healthcare stock market price indicators, traders can identify Alignment Healthcare position entry and exit signals to maximize returns.
| Price Series Summation | ||
| Price Series Division | ||
| Inverse Tangent Over Price Movement | ||
| Price Ceiling Movement | ||
| Aroon Oscillator | ||
| Balance Of Power | ||
| Parabolic SAR | ||
| MidPoint over period | ||
| Hanging Man | ||
| Long Line Candle |
Alignment Healthcare Return and Market Media
The median price of Alignment Healthcare for the period between Fri, Oct 10, 2025 and Thu, Jan 8, 2026 is 17.69 with a coefficient of variation of 8.03. The daily time series for the period is distributed with a sample standard deviation of 1.46, arithmetic mean of 18.19, and mean deviation of 1.31. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Did Alignment Healthcares Suvida Deal Just Redefine Its Arizona Medicare Growth Opportunity | 10/22/2025 |
2 | Disposition of 25000 shares by Konowiecki Joseph S of Alignment Healthcare at 18.0 subject to Rule 16b-3 | 10/28/2025 |
3 | Disposition of 180000 shares by John Kao of Alignment Healthcare at 16.3154 subject to Rule 16b-3 | 11/10/2025 |
4 | 1 Growth Stock with All-Star Potential and 2 Facing Headwinds | 11/20/2025 |
5 | 3 Big Reasons to Love Alignment Healthcare | 12/05/2025 |
6 | Disposition of 19706 shares by Christopher Joyce of Alignment Healthcare at 19.3294 subject to Rule 16b-3 | 12/08/2025 |
7 | Disposition of 180000 shares by John Kao of Alignment Healthcare at 19.0179 subject to Rule 16b-3 | 12/10/2025 |
8 | Disposition of 11119494 shares by General Atlantic, L.p. of Alignment Healthcare at 18.57 subject to Rule 16b-3 | 12/12/2025 |
9 | Disposition of 113319 shares by Dawn Maroney of Alignment Healthcare at 20.0068 subject to Rule 16b-3 | 12/15/2025 |
10 | Alignment Healthcare to Present at the 44th Annual J.P. Morgan Healthcare Conference | 12/17/2025 |
11 | Disposition of 888 shares by Christopher Joyce of Alignment Healthcare at 19.3818 subject to Rule 16b-3 | 12/29/2025 |
12 | Disposition of 100000 shares by Dawn Maroney of Alignment Healthcare at 20.0345 subject to Rule 16b-3 | 01/02/2026 |
13 | Disposition of 228152 shares by Dawn Maroney of Alignment Healthcare at 21.3349 subject to Rule 16b-3 | 01/06/2026 |
14 | Does This Valuation Of Alignment Healthcare, Inc. Imply Investors Are Overpaying | 01/07/2026 |
About Alignment Healthcare Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Alignment or other stocks. Alpha measures the amount that position in Alignment Healthcare LLC has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 | 2026 (projected) | Interest Debt Per Share | 1.03 | 1.85 | 1.66 | 0.91 | Revenue Per Share | 9.79 | 14.17 | 12.75 | 6.5 |
Alignment Healthcare Upcoming Company Events
As portrayed in its financial statements, the presentation of Alignment Healthcare's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Alignment Healthcare's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Alignment Healthcare's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Alignment Healthcare. Please utilize our Beneish M Score to check the likelihood of Alignment Healthcare's management manipulating its earnings.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Alignment Healthcare
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Alignment Healthcare Backtesting, Alignment Healthcare Valuation, Alignment Healthcare Correlation, Alignment Healthcare Hype Analysis, Alignment Healthcare Volatility, Alignment Healthcare History and analyze Alignment Healthcare Performance. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Alignment Healthcare technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.